← Back to Search

kinesio tape for Multiple Sclerosis (KITAMS Trial)

N/A
Waitlist Available
Led By Emerson Sebastiao, PhD
Research Sponsored by Northern Illinois University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10minutes
Awards & highlights

Summary

This trial tests if applying Kinesio Tape can improve balance, mobility, and physical function in people with Multiple Sclerosis (MS) aged 18 to 55. The tape supports muscles and joints, reduces pain, and improves circulation. Participants will be assessed on their balance and mobility at different stages of the trial. Kinesio tape (KT) was developed by Dr. Kenso Kase in the 1970s and gained popularity after being used by athletes in the 2008 Olympic Games.

Eligible Conditions
  • Multiple Sclerosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Six-minute Walking Test
Six-spot Step Test
Static Balance Performance
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Kinesio Tape (KTG)Experimental Treatment1 Intervention
Participants allocated into the KTG will receive a single time application of the kinesio tape flexible tape (Kinesio® Tex, Albuquerque, NM, USA) in the upper-body (i.e., back part of the trunk) and in the lower-body (i.e., legs and ankle) according to standardized procedures (https://kinesiotaping.com/how-to/). The tape is latex-free and wearable for weeks without causing skin irritation (i.e., hypoallergenic); and safe for populations ranging from pediatric to geriatric. The tape will be applied by a Physical Therapist with experience in tape application. Tape application will be conducted in a private room with a complete structure for the procedure.
Group II: Sham Tape (STG)Placebo Group1 Intervention
Participants allocated into the STG will receive a single time application of an inflexible tape (i.e., sham tape) in the same body segments as the intervention condition. Tape application will be conducted in a private room with a complete structure for the procedure.

Find a Location

Who is running the clinical trial?

Northern Illinois UniversityLead Sponsor
8 Previous Clinical Trials
917 Total Patients Enrolled
Emerson Sebastiao, PhDPrincipal InvestigatorDepartment of Kinesiology and Physical Education - Northern Illinois University
~4 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top